A detailed history of Wellington Management Group LLP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 465,112 shares of XERS stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
465,112
Previous 471,644 1.38%
Holding current value
$1.67 Million
Previous $1.34 Million 17.26%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$2.78 - $3.73 $18,158 - $24,364
-6,532 Reduced 1.38%
465,112 $1.58 Million
Q3 2024

Nov 14, 2024

BUY
$2.06 - $2.96 $102,042 - $146,623
49,535 Added 11.74%
471,644 $1.34 Million
Q2 2024

Aug 13, 2024

BUY
$1.7 - $2.45 $42,778 - $61,651
25,164 Added 6.34%
422,109 $949,000
Q1 2024

May 15, 2024

BUY
$2.04 - $3.22 $809,767 - $1.28 Million
396,945 New
396,945 $877,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $488M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.